These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3918559)

  • 41. Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.
    Köller U; Majdic O; Liszka K; Stockinger H; Pabinger-Fasching I; Lechner K; Knapp W
    Clin Exp Immunol; 1985 Mar; 59(3):613-21. PubMed ID: 3921299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human immunodeficiency virus infection in hemophilia patients: a 4-year prospective study.
    Beth-Giraldo E; Giraldo G; De Biasi R; Miraglia E; Castello G; Monaco M; Perna M; Zarrilli D; Piazza M; Tullio Cataldo P
    Antibiot Chemother (1971); 1987; 38():66-79. PubMed ID: 3499114
    [No Abstract]   [Full Text] [Related]  

  • 43. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
    Funk M; Ebener U; Kreuz W; Ehrenforth S
    Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs.
    Böttiger B; Blombäck M; Berntorp E; Egberg N; Nilsson IM; Schulman S; Stigendal L; Biberfeld G
    Eur J Haematol; 1988 Nov; 41(5):459-66. PubMed ID: 2905274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generalized lymphadenopathy and T cell abnormalities in hemophilia A.
    Gill JC; Menitove JE; Wheeler D; Aster RH; Montgomery RR
    J Pediatr; 1983 Jul; 103(1):18-22. PubMed ID: 6223133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of common congenital disorders of haemostasis.
    Ekert H
    Paediatrician; 1980; 9(2):81-8. PubMed ID: 6771736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease.
    Beddall AC; Enayat SM; Williams CE; Short PE; Hill FG
    J Clin Pathol; 1984 Sep; 37(9):1035-9. PubMed ID: 6432854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.
    Sabin CA; Pasi KJ; Phillips AN; Lilley P; Bofill M; Lee CA
    BMJ; 1996 Jan; 312(7025):207-10. PubMed ID: 8563582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunologic abnormalities in patients with hemophilia A.
    Weintrub PS; Koerper MA; Addiego JE; Drew WL; Lennette ET; Miner R; Cowan MJ; Ammann AJ
    J Pediatr; 1983 Nov; 103(5):692-5. PubMed ID: 6415259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
    Bennett B
    Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
    [No Abstract]   [Full Text] [Related]  

  • 55. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study.
    Goedert JJ; Cohen AR; Kessler CM; Eichinger S; Seremetis SV; Rabkin CS; Yellin FJ; Rosenberg PS; Aledort LM
    Lancet; 1994 Sep; 344(8925):791-2. PubMed ID: 7916077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies against Australia-antigen in haemophilia.
    Nordenfelt E; Nilsson IM
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
    [No Abstract]   [Full Text] [Related]  

  • 57. [Characterization of immune disorders in hemophiliac patients with the identification of inhibitor-dependence in replacement transfusion therapy].
    Rudenko VP; Stasyshyn OV; Lebed' HB; Orlyk VV; Lohins'kyĭ VIe
    Lik Sprava; 2001; (3):39-43. PubMed ID: 11560024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
    Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
    Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune status of blood product recipients.
    Jason J; Hilgartner M; Holman RC; Dixon G; Spira TJ; Aledort L; Evatt B
    JAMA; 1985 Feb; 253(8):1140-5. PubMed ID: 3918187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.